The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Tuberculosis Diagnostics Market From 2026 To 2030?
The tuberculosis diagnostics market size has experienced robust growth over recent years. Forecasts indicate it will expand from $2.34 billion in 2025 to $2.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this historical expansion include the worldwide prevalence of tuberculosis disease, the increase in public health screening initiatives, the widespread availability of smear microscopy infrastructure, international financial support for TB control efforts, and the uptake of culture-based diagnostic methods.
The tuberculosis diagnostics market size is set to experience significant expansion in the upcoming years. It is projected to reach $3.37 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. The expansion during the forecast period can be attributed to the rising demand for quick and accurate TB diagnosis, an increased focus on detecting drug-resistant TB, the growth of decentralized diagnostic testing, greater investments in molecular diagnostics, and the integration of AI-assisted diagnostic instruments. Key trends for the forecast period include the increasing uptake of molecular TB testing methods, a growing reliance on rapid diagnostic platforms, the expanding integration of drug resistance detection, the spread of point-of-care TB testing, and an intensified focus on high-sensitivity diagnostics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp
What Key Drivers Are Influencing The Growth Of The Tuberculosis Diagnostics Market?
The increasing occurrence of tuberculosis is fueling the demand within the tuberculosis diagnostics market moving forward. Tuberculosis (TB) is a contagious bacterial infection primarily affecting the lungs, requiring timely detection to prevent severe complications and transmission. The rise in the incidence of tuberculosis (TB) is attributed to the increasing prevalence of HIV/AIDS, which severely compromises the immune system and renders individuals highly susceptible to developing active tuberculosis disease. The elevated incidence of tuberculosis consequently supports the tuberculosis diagnostics sector by boosting the need for rapid, accurate, and point-of-care diagnostic tests that enable early treatment initiation and better disease management. For instance, in October 2025, according to the UK Health Security Agency, a government agency responsible for all health security in England, Tuberculosis levels in England increased by 13.6 percent in 2024 compared with 2023, with 5,490 notifications reported in 2024 compared to 4,831 in 2023. Therefore, the growing incidence of tuberculosis is propelling the expansion of the tuberculosis diagnostics market.
Which Segments Are Included In The Analysis Of The Tuberculosis Diagnostics Market?
The tuberculosis diagnostics market covered in this report is segmented –
1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Subsegments:
1) By Radiographic Tests: Chest X-rays, CT Scans
2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures
9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques
Which Trends Are Impacting The Growth Of The Tuberculosis Diagnostics Market?
Key players in the tuberculosis diagnostics sector are concentrating on product advancements and creating novel solutions, such as tuberculosis diagnostic tests, to enhance their market standing. Tuberculosis diagnostic tests are medical examinations and laboratory procedures used to determine if an individual is infected with Mycobacterium tuberculosis, the bacteria responsible for TB. These assessments aid in detecting active TB disease, latent TB infection, and drug-resistant strains, allowing for the swift commencement of appropriate treatment. For instance, in February 2023, Redcliffe Labs, an India-based technology-driven diagnostics service provider, unveiled the BD MAX MDR TB (Tuberculosis) test. This diagnostic test enables clinicians to rapidly screen for tuberculosis and multidrug resistance as a primary assessment, performed on the BD MAX molecular diagnostic system. Healthcare professionals utilize this test to simultaneously identify TB-causing bacteria and ascertain if the bacteria harbor mutations associated with resistance to two vital first-line drugs, Isoniazid (INH) and Rifampicin (RIF).
Which Key Industry Participants Are Active In The Tuberculosis Diagnostics Market?
Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio
Read the full tuberculosis diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Tuberculosis Diagnostics Market?
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Tuberculosis Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8165&type=smp
Browse Through More Reports Similar to the Global Tuberculosis Diagnostics Market 2026, By The Business Research Company
Infectious Disease Diagnostics Testing Market Report 2026
Medical And Diagnostic Laboratory Services Market Report 2026
Clinical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model